These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13598255)

  • 1. [Renal function in malignant blood diseases. I. Frequency of urinary changes and azotemia in malignant blood diseases].
    VERCILLO L
    Haematologica; 1958; 43(7):623-32. PubMed ID: 13598255
    [No Abstract]   [Full Text] [Related]  

  • 2. Short- and long-term follow-up of glomerular and tubular renal markers of kidney function in hyperthyroid cats after treatment with radioiodine.
    van Hoek I; Lefebvre HP; Peremans K; Meyer E; Croubels S; Vandermeulen E; Kooistra H; Saunders JH; Binst D; Daminet S
    Domest Anim Endocrinol; 2009 Jan; 36(1):45-56. PubMed ID: 19010632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal complications of malignant hemopathies].
    ARDAILLOU R; SLAMA R
    Pathol Biol; 1961 May; 9():1049-60. PubMed ID: 13684066
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
    Miralbell R; Sancho G; Bieri S; Carrió I; Helg C; Brunet S; Martin PY; Sureda A; Gomez De Segura G; Chapuis B; Estorch M; Ozsahin M; Keller A
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):809-16. PubMed ID: 14967438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
    Schmidt MK; Reynolds CA; Estrada AH; Prosek R; Maisenbacher HW; Sleeper MM; Oyama MA
    J Vet Cardiol; 2009 May; 11 Suppl 1():S81-6. PubMed ID: 19394913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury.
    Kellum JA
    Crit Care Med; 2008 Apr; 36(4 Suppl):S141-5. PubMed ID: 18382185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
    Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
    Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible correlation between changes of the blood protein picture and auditory function in the course of several blood diseases].
    ESPOSITO S; GANDOLFI M
    Minerva Otorinolaringol; 1958 May; 8(5):142-6. PubMed ID: 13552413
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal protective function in surgical treatment for chronic infrarenal aortic aneurysms].
    Neĭmark MI; Merkulov IV; Flat MK
    Anesteziol Reanimatol; 2005; (4):18-22. PubMed ID: 16206579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus does not preclude stabilization or improvement of renal function after stent revascularization in patients with kidney insufficiency and renal artery stenosis.
    Silva JA; Potluri S; White CJ; Collins TJ; Jenkins JS; Subramanian R; Ramee SR
    Catheter Cardiovasc Interv; 2007 May; 69(6):902-7. PubMed ID: 17192944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The serum protein disorders in the malignant blood diseases].
    CROIZAT P; CREYSSEL R
    Rev Prat; 1961 Feb; 11():587-96. PubMed ID: 13696529
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationships between oxidative stress markers and red blood cell characteristics in renal azotemic dogs.
    Buranakarl C; Trisiriroj M; Pondeenana S; Tungjitpeanpong T; Jarutakanon P; Penchome R
    Res Vet Sci; 2009 Apr; 86(2):309-13. PubMed ID: 18667217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of transplantation of unrelated cord blood in children with malignant and non-malignant diseases: an Utrecht-Prague collaborative study.
    Boelens JJ; Bierings M; Tilanus M; Lie J; Sedlacek P
    Bone Marrow Transplant; 2009 Apr; 43(8):655-7. PubMed ID: 18997829
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathological anatomy of malignant blood diseases].
    CHOME J
    Gaz Med Fr; 1958 Apr; 65(7):685-6. PubMed ID: 13548352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the results obtained by the chemotherapy of malignant blood diseases].
    BERNARD J; MATHE G
    Concours Med; 1958 Feb; 80(7):789-90. PubMed ID: 13511917
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current clinical & therapeutic facts in the field of malignant blood diseases].
    DEBRAY
    Concours Med; 1957 May; 79(20):2439-42. PubMed ID: 13437654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of results obtained in malignant blood diseases by means of chemotherapy].
    BERNARD J; MATHE G
    Prensa Med Argent; 1958 Jun; 45(26):2358-60. PubMed ID: 13623653
    [No Abstract]   [Full Text] [Related]  

  • 18. [Remarks on the development of malignant blood diseases].
    BERNARD J; MATHE G
    Prensa Med Argent; 1958 Jun; 45(26):2360-2. PubMed ID: 13623654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Place of roentgentherapy in malignant blood diseases].
    FAURE C; VALLEE G
    Concours Med; 1958 Nov; 80(47):5019-21 passim. PubMed ID: 13609130
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxychlorine in cytostatic therapy of malignant blood diseases.
    CONSOLI G
    Minerva Med; 1955 May; 46(39):1386-8. PubMed ID: 14393802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.